Lind Kevin Robert 4
4 · Longboard Pharmaceuticals, Inc. · Filed Feb 11, 2022
Insider Transaction Report
Form 4
Lind Kevin Robert
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-09+195,000→ 195,000 totalExercise: $4.20Exp: 2032-02-08→ Voting common stock (195,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2022.